Clinical Trials Browser

NCT03574792 2026-04-16

Gabapentin, Methadone, and Oxycodone With or Without Venlafaxine Hydrochloride in Managing Pain in Participants With Stage II-IV Squamous Cell Head and Neck Cancer Undergoing Chemoradiation Therapy

Phase 2 Completed

62 enrolled 10 charts

DermatologicHead & Neck

Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8

NCT01384513 2026-04-15

A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies

Phase 2 Completed

40 enrolled 15 charts

Classical hematologyDermatologicLymphoidMyeloidOther hematologic neoplasmPlasma cell

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Anemia, Aplastic, Anemia, Refractory, Hodgkin Disease, Leukemia, Hairy Cell, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Mastocytosis, Multiple Myeloma, Mycosis Fungoides, Myeloproliferative Disorders, Polycythemia Vera, Recurrence, Sezary Syndrome, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell, Leukemia, Myelomonocytic, Juvenile, Primary Myelofibrosis

Clinical Trials

Gabapentin, Methadone, and Oxycodone With or Without Venlafaxine Hydrochloride in Managing Pain in Participants With Stage II-IV Squamous Cell Head and Neck Cancer Undergoing Chemoradiation Therapy

A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies

MELANFα

Phase Ib of L-NMMA and Pembrolizumab

Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic Melanoma

Peripheral T Cell Determinants of Response and Resistance to Pembrolizumab in Melanoma

Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases

STARS

Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma

Investigation of Mohs Surgical Margins Using Two Photon Microscopy

iSITE

Pilot Study Evaluating the Efficacy and Safety of Metformin in Melanoma

AMMAM

DOPACER

TICIMEL

Denosumab + PD-1 in Subjects With Stage III/ IV Melanoma

Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma

NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts

PALANGI3

Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor

Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases

IMMUMELA

Clinical and Functional Retinal Changes Associated With BRAF/MEK Inhibitor Therapy in Patients With Malignant Melanoma

Effects of Lavender Aromatherapy on Patient Anxiety During Mohs Micrographic Surgery

IKKb-matured, RNA-loaded Dendritic Cells for Metastasised Uveal Melanoma

Optimizing the Timing for Facial Surgical Dressing Removal

MAK

Match Mel

Study of Trametinib + Ceritinib in Patients With Unresectable Melanoma

LAPAM

ctDNA

Retinal Structural and Functional Changes in Patients Treated With BRAF/MEK Inhibitors

Vemurafenib With Lymphodepletion Plus Adoptive Cell Transfer & High Dose IL-2 Metastatic Melanoma

Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination With Nivo. in Melanoma Patients

Imaging Techniques to Monitor Photosensitizer and sO2 Levels During Photodynamic Therapy of Actinic Keratoses

O-Mel-Sora

Nivolumab Plus Relatlimab in Patients With Metastatic Uveal Melanoma

RW-HPN-MF-01

A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas

EUREKA

Impact of Skin Type on Wonud Healing and Scarring Following Facial Skin Surgery

Assessing Patient Anxiety During Mohs Micrographic Surgery

Dendritic Cells Plus Autologous Tumor RNA in Uveal Melanoma

Pilot Study of Biomarkers of Response to Immune Checkpoint Blockade in Metastatic Melanoma

The Use of Dendritic Cell/Tumor Hybridomas as a Novel Tumor Vaccine in Patients With Advance Melanoma

Topical Chemoprevention of Skin Cancer Biomarkers

MELCIRC

Interactive Tailored Website to Promote Sun Protection and Skin Self-Check Behaviors in Patients With Melanoma

ANDAL-SK

Low Dose Ipilimumab With Pembrolizumab in Treating Patients With Melanoma That Has Spread to the Brain